The Lancet, 01 April 2023, Volume 401, Issue 10382, Pages 1053-1130
Explore the current issue of The Lancet, a world leading medical journal published weekly since 1823
Related Articles
Air pollution exposure and cardiometabolic risk
The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with…
Glycaemic index as part of the diabetes prevention strategy
The study by Victoria Miller and colleagues1 in The Lancet Diabetes & Endocrinology adds to and extends the growing body of evidence of the importance…
Association of glycaemic index and glycaemic load with type 2 diabetes and related conditions in prospective studies
There is debate over the nature of the carbohydrate-containing foods that should be recommended to reduce the risk of type 2 diabetes and related conditions.…
The future of valvular heart disease assessment and therapy
Valvular heart disease (VHD) is becoming more prevalent in an ageing population, leading to challenges in diagnosis and management. This two-part Series offers a comprehensive…
Valvular heart disease: from mechanisms to management
Valvular heart disease is common and its prevalence is rapidly increasing worldwide. Effective medical therapies are insufficient and treatment was historically limited to the surgical…
Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study
Diets with a high glycaemic index and a high glycaemic load were associated with a higher risk of incident type 2 diabetes in a multinational…
Association of Pick’s disease with the MAPT H2 haplotype
One of the main players in the pathogenesis of neurodegenerative diseases is the microtubule-associated protein tau. Tau aggregation is involved in Alzheimer’s disease, in which…
MAPT H2 haplotype and risk of Pick’s disease in the Pick’s disease International Consortium: a genetic association study
The Pick’s disease International Consortium provides an opportunity to do large studies to enhance our understanding of the pathobiology of Pick’s disease. This study shows…
The Lancet, 20 April 2024, Volume 403, Issue 10436, Pages 1513-1602
Explore the current issue of The Lancet, a world leading medical journal published weekly since 1823
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
In patients where antidrug antibodies were detected, remission was less likely to be reached and sustained, and infusion reaction or discontinuation of infliximab was more…
